Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.

d99888e6.R851GHVO--IMImxZswskBMXLUvFanPJe15StkZmClsU.f_w7egwMmoZbETUy501nVJSkarMs1p9okuKd28zu3b0IpzNfAjiI0ERJWA~e7f6a9a80a236af90be668f028efa373

Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.

11/09/2026

Extraordinary General Meeting

07:30 am

Past events on DaShenLin Pharmaceutical Group Co., Ltd.

25/08/2026

Earnings release - Q2 2026

18/05/2026

Earnings presentation

01:30 pm
18/05/2026

Annual General Meeting

06:30 am
24/04/2026

Earnings release - Annual 2025

24/04/2026

Earnings release - Q1 2026

30/03/2026

Extraordinary General Meeting

07:30 am
09/12/2025

Earnings presentation

01:30 pm
21/11/2025

Extraordinary General Meeting

07:30 am
30/10/2025

Earnings release - Q3 2025

26/09/2025

Earnings presentation

01:30 pm
15/09/2025

Extraordinary General Meeting

08:00 am

Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.

26/06/2026

Ex-dividend date - 0.49 CNY

09:30 am
06/11/2025

Ex-dividend date - 0.34 CNY

10:30 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million CNY
Released
Forecast
Spread
24 531
24 720
-0.76%
26 497
26 779
-1.05%
27 502
27 576
-0.27%

29 540


32 521


35 823

EBITDA
Million CNY
Released
Forecast
Spread
2 119
2 532
-16.31%
3 395
3 349
1.4%
3 833
3 281
16.84%

3 828


4 204


4 651

EBIT
Million CNY
Released
Forecast
Spread
1 632
1 868
-12.66%
1 501
1 673
-10.32%
2 038
1 881
8.36%

2 324


2 643


2 997

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
1 628
1 807
-9.91%
1 340
1 496
-10.42%
1 849
1 702
8.66%

2 212


2 540


2 885

Net income
Million CNY
Released
Forecast
Spread
1 166
1 303
-10.51%
915
1 152
-20.57%
1 235
1 186
4.15%

1 486


1 711


1 937

EPS
CNY
Released
Forecast
Spread
1,03
1,15
-10.59%
0,81
1,05
-23.07%
1,08
1,04
4.26%

1,30


1,50


1,70

Announcement Date28/04/2425/04/2523/04/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4 2028 Q1 2028 Q2
Net sales
Million CNY
Released
Forecast
Spread
6 766
7 282
-7.09%
6 956
7 159
-2.84%
6 567
7 200
-8.79%
6 546
6 554
-0.12%
7 434
7 262
2.37%
6 973
7 184
-2.93%
7 018
7 281
-3.62%

7 336


8 306


8 156


7 845


7 670


8 426


9 252


9 071

EBITDA
Million CNY
Released
Forecast
Spread

613


827


882


791


682


1 066


996


939


741


1 258


1 175


1 045


900


1 406


1 314

EBIT
Million CNY
Released
Forecast
Spread
230


650


476
403
18%
410
330
24.26%
502
226
122.08%
710
692
2.64%
616
568
8.48%

575


362


737


683


627


482


974


882

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
160
146
10%
649
362
79.29%
474
404
17.44%
398
314
26.73%
327
215
52.58%
707
670
5.55%
616
598
3.13%

535


326


808


723


593


446


937


843

Net income
Million CNY
Released
Forecast
Spread
56,6
75,8
-25.28%
460
255
80.19%
338
276
22.59%
283
192
47%
154
130
18.36%
511
521
-1.87%
416
423
-1.7%

363


193


614


517


386


228


715


601

EPS
CNY
Released
Forecast
Spread
0,06
0,11
-44.88%
0,40
0,31
29.85%
0,30
0,24
22.92%
0,25
0,18
39.3%
0,13
0,08
59.55%
0,45
0,44
3.26%
0,36
0,34
6.8%

0,34


0,15


0,43


0,37


0,33


0,36


0,63


0,53

Announcement Date25/04/2525/04/2528/08/2529/10/2523/04/2623/04/2624/08/26--------

Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
  4. Calendar DaShenLin Pharmaceutical Group Co., Ltd.